Search Results - P. A. Shesternya
- Showing 1 - 20 results of 33
- Go to Next Page
-
1
New Opportunities for Determining the Terms of Carrying out the Control Coronarangiography after Percutaneous Coronary Intervention by D. A. Brusentsov, P. A. Shesternya
Published 2020-09-01Background. Coronary heart disease is the leading cause of death in the Russian Federation, causing social and economic damage to the state. Previously published studies showed the association of rs1800470 polymorphism of the gene of the transforming growth factor-β1 (TGF-β1) with the risk of develo...
Get full text
Article -
2
GENETIC ASPECTS OF MYOCARDIAL INFARCTION: PROBLEMS AND PERSPECTIVES by P. A. Shesternya, V. A. Shulman, S. Yu. Nikulina
Published 2012-02-01The role of hereditary factors in the development of coronary heart disease and myocardial infarction is known, but the underlying pathogenetic mechanisms remain understudied. Multiple studies of candidate genes (those coding protein synthesis, participating in atherosclerosis pathogenesis, or regul...
Get full text
Article -
3
Angiographic dynamics of coronary flow state after percutaneous coronary intervention in carriers of polymorphic RS1800470 variants of the TGF-β1 gene by D. A. Brusentsov, S. Yu. Nikulina, P. A. Shesternya
Published 2019-09-01Aim. To study the relationship between the angiographic dynamics of the state of the coronary bed in patients undergoing percutaneous coronary intervention (PCI) due to myocardial infarction (MI) and the carriage of polymorphic rs1800470 variants of the transforming growth factor beta-1 gene (TGF-β1...
Get full text
Article -
4
Analysis of safety of bioactive concentrate of small sea fish therapy in comorbid patients with osteoarthritis by O. V. Zimnitskaya, M. M. Petrova, P. A. Shesternya
Published 2021-06-01The article discusses the safety issues of a bioactive concentrate of small sea fish (BCSSF, Alflutop®) in the treatment of osteoarthritis (OA). The data of original studies, which were published during 2001–2021 years, from eLIBRARY, PubMed and Web of Science databases were analyzed. The selection...
Get full text
Article -
5
ASSOCIATION BETWEEN ANXIETY-DEPRESSIVE SPECTRUM DISORDERS AND JOINT DISEASE IN WOMEN by A. O. Vasilyeva, P. A. Shesternya, M. M. Petrova
Published 2018-01-01The frequency of anxiety-depressive spectrum disorders (ADSDs) in patients with rheumatic diseases (RDs) is much higher than that in the general population. ADSDs are known to be associated with pain intensity, disease activity, and functional limitations. However, the majority of available papers a...
Get full text
Article -
6
IMPACT OF LOCUS 9P21.3 SINGLE NUCLEOTIDE POLYMORPHISMS ON CORONARY ATHEROSCLEROSIS SEVERITY AND LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH MYOCARD... by P. A. Shesternya, G. V. Matyushin, S. Yu. Nikulina, A. S. Sergeeva
Published 2015-09-01Aim. To investigate association between 9p21.3 locus single nucleotide polymorphisms (SNPs) and coronary atherosclerosis severity and long-term outcomes after percutaneous coronary intervention (PCI) in patients with myocardial infarction (MI).Material and methods. A total of 255 Caucasian patients...
Get full text
Article -
7
Association of RS1800470 polymorphic variants of the transforming growth factor β1 (TGF-β1) gene with the severity of coronary atherosclerosis by D. A. Brusentsov, S. Yu. Nikulina, P. A. Shesternya, A. A. Chernova
Published 2018-11-01Aim. To study the relationship of rs1800470 polymorphic variants of the transforming growth factor p1 (TGF-β1) gene with the severity of coronary arteries (CA) atherosclerosis.Material and methods. The study included 256 patients with myocardial infarction (MI) (216 males and 40 females) of a Caucas...
Get full text
Article -
8
Macrophage activation syndrome during pregnancy as a fatal complication of systemic idiopathic arthritis by P. A. Shesternya, V. B. Tskhay, M. I. Bazina, I. V. Matveeva
Published 2025-01-01According to the current concept, juvenile arthritis with a systemic onset (systemic juvenile idiopathic arthritis, sJIA) and adultonset Still's disease (ASD) are considered as rare autoinflammatory diseases, with the underlying immunopathogenesis being based on the mechanisms bridging both of...
Get full text
Article -
9
Comparing effectiveness of tissue and plasma plasminogen activator thrombolysis in patients with various severity of acute myocardial infarction by V. A. Shulman, S. E. Golovenkin, V. V. Rodionov, G. V. Matyushin, P. A. Shesternya
Published 2005-12-01Aim. To compare alteplase (AL) and streptokinase (SK) effectiveness in patients with various severity of acute myocardial infarction (AMI). Material and methods. In retrospective analysis, 650 AMI patients were divided into three groups. Group I consisted of 183 subjects administered AL, Group II Р...
Get full text
Article -
10
Dissociation of clinical symptoms and magnetic resonance imaging data in axial psoriatic arthritis by A. O. Vasilieva, D. E. Filipenko, E. V. Kapustina, N. V. Popov, P. A. Shesternya
Published 2023-12-01Currently, there is no generally accepted definition of axial lesions in psoriatic arthritis (axPsA), and the diagnostic criteria are extrapolated from the recommendations for ankylosing spondylitis and axial spondyloarthritis.Objective: To evaluate data of magnetic resonance imaging (MRI) of spine...
Get full text
Article -
11
Magnetic resonance tomography capabilities and limitations in managing the efficacy of treatment with biological disease modifying anti-rheumatic drugs in ankylosing spondylitis by P. A. Shesternya, O. D. Gritsenko, P. A. Astanin, A. Yu. Stepanenko, N. V. Popov
Published 2021-04-01Extensive use of magnetic resonance imaging (MRI) in clinical practice revolutionized our understanding of the pathogenesis of axis spondyloarthritis (aSpA) and treatment approaches. The use of MRI to diagnose non-radiographic aSpA is well established. At the same time, the possibility of its use fo...
Get full text
Article -
12
The subset composition of follicular T helpers and B lymphocytes in patients with ankylosing spondylitis depending on HLA-B27 status by P. A. Shesternya, A. A. Savchenko, I. V. Kudryavtsev, A. A. Masterova, A. G. Borisov
Published 2024-07-01Immune relationships involved in a wide range of immunopathological conditions, including ankylosing spondylitis (AS), are formed due to the characteristics of the subset composition of follicular T helper cells (Tfh) and B lymphocytes. Expression of the HLA-B27 antigen can change the reactivity of...
Get full text
Article -
13
DRUG-INDUCED ENCEPHALOPATHY WITH IMPAIRED COGNITIVE FUNCTIONS DURING TOCILIZUMAB USE by P. A. Shesternya, S. V. Prokopenko, E. Yu. Mozheiko, O. D. Gritsenko, T. V. Tupaeva, E. M. Kurts
Published 2019-09-01Blockade of interleukin-6 (IL-6) is one of the most promising areas in the treatment of a number of immunoinflammatory diseases. Tocilizumab (TCZ), the first registered anti-IL-6 receptor monoclonal antibody, has been used effectively by rheumatologists since 2010. During this period, the spectrum o...
Get full text
Article -
14
GIANT CELL MYOCARDITIS IN HIV INFECTION: A FATAL TANDEM by S. Yu. Nikulina, P. A. Shesternya, A. K. Kirichenko, A. A. Chernova, D. A. Brusentsov, V. A. Shulman
Published 2018-03-01Giant cell myocarditis (GCM) is a rare autoimmune disease with the leading role of T-cell disorder in its pathogenesis. The associations are known of this disease with various autoimmunities, tumors, drug hypersensitivity. In the literary data there are just single cases of HCM development in HIV in...
Get full text
Article -
15
Pattern of Circulating Microrna's in Patients with Psoriatic Arthritis by P. A. Shesternya, N. A. Shnayder, D. E. Filipenko, E. V. Turchik, А. О. Vasilieva, E. V. Kapustina
Published 2024-03-01Psoriatic arthritis (PsA) is a common rheumatic disease with an extremely variable phenotype. The main domains of PsA are peripheral arthritis, spondylitis, enthesitis and dactylitis. Studying new mechanisms of PsA development can help in finding the key to the development of innovative diagnostic m...
Get full text
Article -
16
CLINICAL SIGNIFICANCE OF CORONARY ARTERY DISEASE GENETIC MARKERS: REALITY OR FAR FUTURE? by P. A. Shesternya, S. Yu. Nikulina, V. A. Shulman, A. S. Sergeeva, A. I. Demkina, V. N. Maksimov, М. I. Voevoda
Published 2014-10-01Aim. The purpose of this study was to access clinical application of the 9p21.3 locusgenotype in patients with myocardial infarction (MI).Material and methods. Totally 500 (411 male, 89 female) patients with MI youngerthan 65 years old [Ме 54,0; Q25 48,0; Q 59,0] and 31 autopsy data (24 male,7 femal...
Get full text
Article -
17
Features of T lymphocyte subpopulation profile in patients with ankylosing spondylitis undergoing genetically engineered biological therapy by A. A. Savchenko, O. D. Gritsenko, A. G. Borisov, I. V. Kudryavtsev, M. K. Serebriakova, A. A. Masterova, P. A. Shesternya
Published 2021-12-01The aim of current study was to compare profiles of T cell subsets in the patients with ankylosing spondylitis (AS) who received different modes of genetically engineered biological therapy (GEBT). The research involved 58 patients aged 20 to 58 years diagnosed with AS and treated with anti-TNFα and...
Get full text
Article -
18
PREDICTIVE ROLE OF CHROMOSOME 9P21.3 POLYMORPHISMS AND THEIR ASSOCIATION WITH FAMILY HISTORY OF CORONARY HEART DISEASE IN PATIENTS WITH MYOCARDIAL INFARCTION by P. A. Shesternya, V. A. Shulman, S. Yu. Nikulina, E. A. Martynova, A. I. Demkina, P. S. Orlov, V. N. Maksimov, M. I. Voevoda
Published 2012-12-01Aim. To investigate the association between single-nucleotide polymorphisms (SNPs) rs10757278 and rs1333049 of the 9p21.3 locus and family history of coronary heart disease (CHD) in myocardial infarction (MI) patients. Material and methods. The MI group (n=243) and the control group (n=280) were com...
Get full text
Article -
19
Resolution of the Council of Experts of May 20, 2023 "Issues of safety in the treatment of a rheumatological patient" by L. I. Alekseeva, O. N. Anoshenkova, N. G. Dolganova, E. S. Zholobova, E. V. Zonova, S. A. Lapshina, M. A. Korolev, L. V. Menshikova, P. A. Shesternya, Yu. P. Chasovskikh
Published 2023-08-01At the meeting of the Expert Council on May 20, the safety of treatment for patients with osteoarthritis (OA), the most common form of joint disease, was discussed. The first step in the treatment of OA should be the administration of symptomatic delayed-acting agents (SYSADOA) and nonsteroidal anti...
Get full text
Article -
20
The clinical status and working capacity in patients included in the All-Russian Psoriatic Arthritis Registry by E. Yu. Loginova, T. V. Korotaeva, Yu. L. Korsakova, E. E. Gubar, P. O. Tremaskina, E. A. Vasilenko, I. N. Kushnir, I. M. Patkikeeva, S. S. Kudishina, P. A. Shesternya, A. V. Petrov, N. A. Kuznetsova, E. L. Nasonov
Published 2020-09-01Objective: to study the clinical characteristics of PsA and working capacity in patients included in the All-Russian PsA Registry.Patients and methods. The investigation enrolled 614 patients aged 19–84 years with psoriasis from 39 subjects the Russian Federation, who were followed up in the All-Rus...
Get full text
Article